Jinwen Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Jinwen Zhang has a total of 62 co-authors. Here are the top co-authors by number of shared publications:
- Yongbo Xue
School of pharmaceutical sciences (Shenzhen), Sun Yat-sen University, Shenzhen, China
9 shared publications - Yonghui Zhang
Huazhong University of Science and Technology
9 shared publications - Guangmin Yao
Huazhong University of Science and Technology
4 shared publications - Yong-Ji Lai
Department of Pharmacy, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
3 shared publications - Zengwei Luo
Hubei Key Laboratory of Natural Medicinal Chemistry and Resource Evaluation, School of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
3 shared publications Hucheng Zhu
Hubei Key Laboratory of Natural Medicinal Chemistry and Resource Evaluation, School of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology
2 shared publications
Latest Publications
- Open Access
- 3 June 2025
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 13 (6) , e0325824
Discovery of natural CdnP inhibitors through structure-based virtual screening and molecular dynamics simulations
Tuberculosis, caused by Mycobacterium tuberculosis , remains one of the most lethal infectious diseases both historically and in the post-coronavirus disease 2019 era. CdnP (Rv2837c) functions as a bifunctional oligoribonuclease and 3′(2′)-phosphoadenosine 5′-phosphate-phosphatase that impedes host immune responses by recognizing bacterial cyclic dinucleotides such as c-di-AMP, which serve as pathogen-associated molecular patterns. Despite its significance, strategies targeting CdnP remain limited. Through high-throughput virtual screening and enzymatic assays, we identified four natural product inhibitors: one coumarin derivative (macrosporusone A) and three flavonoid glucosides (ligustroflavone, rhoifolin, and neodiosmin). Surface plasmon resonance measurements confirmed direct binding of these compounds to CdnP with nanomolar to micromolar affinities. Molecular dynamics simulations elucidated a dual inhibitory mechanism wherein these compounds competitively occupy the product (AMP)-binding site while simultaneously constraining conformational plasticity of the substrate-binding domain. Evolutionary analysis demonstrated that these inhibitors exhibit broad-spectrum activity against bacterial CdnP orthologs while showing minimal inhibition of host-derived 2′,3′-cGAMP-specific phosphodiesterases, suggesting favorable selectivity. Notably, ligustroflavone exhibited superior inhibitory potency. In contrast, FDA-approved phosphodiesterase inhibitors showed poor activity against bacterial orthologs. These findings provide a foundation for developing novel host-directed therapeutics against tuberculosis that could potentially enhance stimulator of interferon genes (STING)-mediated immune responses without exerting selective pressure for antimicrobial resistance. IMPORTANCE: Tuberculosis (TB) remains a leading cause of mortality worldwide, with drug resistance posing a significant challenge to global control efforts. This study represents a major contribution to the field by identifying novel natural product inhibitors targeting CdnP (Rv2837c), a c-di-AMP-specific phosphodiesterase critical for Mycobacterium tuberculosis pathogenesis. The significance of this work lies in its innovative approach to TB therapy by perturbing bacterial nucleotide signaling pathways rather than directly inhibiting bacterial growth. By selectively targeting bacterial CdnP while avoiding host phosphodiesterases, these compounds—particularly ligustroflavone and other flavonoid glucosides—offer a promising foundation for developing host-directed therapeutics with potentially reduced selective pressure for antimicrobial resistance. Furthermore, the detailed structural insights and inhibitory mechanisms elucidated through molecular dynamics simulations provide valuable knowledge for rational drug design. This research bridges natural product discovery with computational biology to address the urgent need for novel TB treatments, especially against drug-resistant strains, presenting a significant advancement toward more effective therapeutic interventions for this persistent global health threat.
- 3 June 2025
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 13 (6) , e0325824
Open AccessDiscovery of natural CdnP inhibitors through structure-based virtual screening and molecular dynamics simulations
Tuberculosis, caused by Mycobacterium tuberculosis , remains one of the most lethal infectious diseases both historically and in the post-coronavirus disease 2019 era. CdnP (Rv2837c) functions as a bifunctional oligoribonuclease and 3′(2′)-phosphoadenosine 5′-phosphate-phosphatase that impedes host immune responses by recognizing bacterial cyclic dinucleotides such as c-di-AMP, which serve as pathogen-associated molecular patterns. Despite its significance, strategies targeting CdnP remain limited. Through high-throughput virtual screening and enzymatic assays, we identified four natural product inhibitors: one coumarin derivative (macrosporusone A) and three flavonoid glucosides (ligustroflavone, rhoifolin, and neodiosmin). Surface plasmon resonance measurements confirmed direct binding of these compounds to CdnP with nanomolar to micromolar affinities. Molecular dynamics simulations elucidated a dual inhibitory mechanism wherein these compounds competitively occupy the product (AMP)-binding site while simultaneously constraining conformational plasticity of the substrate-binding domain. Evolutionary analysis demonstrated that these inhibitors exhibit broad-spectrum activity against bacterial CdnP orthologs while showing minimal inhibition of host-derived 2′,3′-cGAMP-specific phosphodiesterases, suggesting favorable selectivity. Notably, ligustroflavone exhibited superior inhibitory potency. In contrast, FDA-approved phosphodiesterase inhibitors showed poor activity against bacterial orthologs. These findings provide a foundation for developing novel host-directed therapeutics against tuberculosis that could potentially enhance stimulator of interferon genes (STING)-mediated immune responses without exerting selective pressure for antimicrobial resistance. IMPORTANCE: Tuberculosis (TB) remains a leading cause of mortality worldwide, with drug resistance posing a significant challenge to global control efforts. This study represents a major contribution to the field by identifying novel natural product inhibitors targeting CdnP (Rv2837c), a c-di-AMP-specific phosphodiesterase critical for Mycobacterium tuberculosis pathogenesis. The significance of this work lies in its innovative approach to TB therapy by perturbing bacterial nucleotide signaling pathways rather than directly inhibiting bacterial growth. By selectively targeting bacterial CdnP while avoiding host phosphodiesterases, these compounds—particularly ligustroflavone and other flavonoid glucosides—offer a promising foundation for developing host-directed therapeutics with potentially reduced selective pressure for antimicrobial resistance. Furthermore, the detailed structural insights and inhibitory mechanisms elucidated through molecular dynamics simulations provide valuable knowledge for rational drug design. This research bridges natural product discovery with computational biology to address the urgent need for novel TB treatments, especially against drug-resistant strains, presenting a significant advancement toward more effective therapeutic interventions for this persistent global health threat.
- 17 February 2020
- Published by Wiley in ChemistrySelect
- Vol. 5 (7) , 2214-2218
Wortmannolol Induces Breast Cancer Cell Death In Vitro and In Vivo by Targeting Phosphoinositide 3‐Kinaseα
- 17 February 2020
- Published by Wiley in ChemistrySelect
- Vol. 5 (7) , 2214-2218
Wortmannolol Induces Breast Cancer Cell Death In Vitro and In Vivo by Targeting Phosphoinositide 3‐Kinaseα
- Open Access
- 1 September 2019
- Published by Springer Nature in Revista Brasileira de Farmacognosia
- Vol. 29 (5) , 637-643
Protective effect of kinsenoside on acute alcohol-induced liver injury in mice
- 1 September 2019
- Published by Springer Nature in Revista Brasileira de Farmacognosia
- Vol. 29 (5) , 637-643
Open AccessProtective effect of kinsenoside on acute alcohol-induced liver injury in mice
- Open Access
- 20 February 2019
- Published by Wiley in BioMed Research International
- Vol. 2019, 1-10
Anti-Inflammatory Activities of Leaf Oil from Cinnamomum subavenium In Vitro and In Vivo
The study determined the chemical constituents and anti-inflammatory effects of leaf oil from Cinnamomum subavenium (CS-LO) that has been used in folk medicine to treat various symptoms including inflammation. The anti-inflammatory effects of the oil were evaluated by LPS-stimulated RAW264.7 cells and the Carr-induced hind mouse paw edema model, respectively. In vitro, nitric oxide (NO), prostaglandin E2 (PGE2), TNF-α, IL-6, and IL-1β were significantly decreased by CS-LO, and the expression of nuclear factor-κB (NF-κB) protein was blocked as well. In in vivo, the malondialdehyde (MDA) and paw edema levels were decreased by CS-LO, and the same result came up on the NO and tumor necrosis factor (TNF-a) of serum at the 5th h after Carr injection. In addition, iNOS and COX-2 immunoreactive cells of the paw tissue were decreased significantly by CS-LO (200 mg/kg) in histological examination. The present findings indicated that CS-LO have anti-inflammatory properties, and the effects might be caused through inhibiting iNOS, COX-2, TNF-α, IL-1β, and IL-6 expression via affecting NF-κB pathway, which will provide a power scientific basis for CS-LO to be used as the treatment of inflammatory diseases.
- 20 February 2019
- Published by Wiley in BioMed Research International
- Vol. 2019, 1-10
Open AccessAnti-Inflammatory Activities of Leaf Oil from Cinnamomum subavenium In Vitro and In Vivo
The study determined the chemical constituents and anti-inflammatory effects of leaf oil from Cinnamomum subavenium (CS-LO) that has been used in folk medicine to treat various symptoms including inflammation. The anti-inflammatory effects of the oil were evaluated by LPS-stimulated RAW264.7 cells and the Carr-induced hind mouse paw edema model, respectively. In vitro, nitric oxide (NO), prostaglandin E2 (PGE2), TNF-α, IL-6, and IL-1β were significantly decreased by CS-LO, and the expression of nuclear factor-κB (NF-κB) protein was blocked as well. In in vivo, the malondialdehyde (MDA) and paw edema levels were decreased by CS-LO, and the same result came up on the NO and tumor necrosis factor (TNF-a) of serum at the 5th h after Carr injection. In addition, iNOS and COX-2 immunoreactive cells of the paw tissue were decreased significantly by CS-LO (200 mg/kg) in histological examination. The present findings indicated that CS-LO have anti-inflammatory properties, and the effects might be caused through inhibiting iNOS, COX-2, TNF-α, IL-1β, and IL-6 expression via affecting NF-κB pathway, which will provide a power scientific basis for CS-LO to be used as the treatment of inflammatory diseases.
- 1 February 2018
- Published by Springer Nature in Current Medical Science
- Vol. 38 (1) , 11-18
Kinsenoside: A Promising Bioactive Compound from Anoectochilus Species
Kinsenoside is a main active component isolated from plants of the genus Anoectochilus, and exhibits many biological activities and pharmacological effects, including hepatoprotective, anti-hyperglycemic, anti-hyperliposis, anti-inflammatory, vascular protective and anti-osteoporosis effects and so on, which is contributing to its promising potency in disease treatments. This review aims to recapitulate the pharmacological functions of kinsenoside, as well as its source, extraction, identification, quantitative analysis, pharmacokinetics, synthesis and patent information. The data reported in this work can confirm the therapeutic potential of kinsenoside and provide useful information for further new drug development.
- 1 February 2018
- Published by Springer Nature in Current Medical Science
- Vol. 38 (1) , 11-18
Kinsenoside: A Promising Bioactive Compound from Anoectochilus Species
Kinsenoside is a main active component isolated from plants of the genus Anoectochilus, and exhibits many biological activities and pharmacological effects, including hepatoprotective, anti-hyperglycemic, anti-hyperliposis, anti-inflammatory, vascular protective and anti-osteoporosis effects and so on, which is contributing to its promising potency in disease treatments. This review aims to recapitulate the pharmacological functions of kinsenoside, as well as its source, extraction, identification, quantitative analysis, pharmacokinetics, synthesis and patent information. The data reported in this work can confirm the therapeutic potential of kinsenoside and provide useful information for further new drug development.
- Open Access
Two New Bioactive α-Pyrones from Hypericum japonicum
Hypericum japonicum (Guttiferae), a type of annual or perennial herb, has been historically applied to cure infectious hepatitis, acute and chronic hepatitis, gastrointestinal disorder, and internal hemorrhage. In our successive studies on the genus Hypericum, two new α-pyrones termed japopyrones A and B (1 and 2) were isolated from H. japonicum. Their structures and absolute configurations were established by the comprehensive analyses of spectroscopic data, the application of the Single-crystal X-ray diffraction structural analysis, and the experimental electronic circular dichroism (ECD) spectra. Bioactivity screenings suggested that compound 2 possessed the potential inhibition efficacy on lytic replication of Kaposi’s sarcoma associated herpesvirus (KSHV) with an IC50 29.46 μM and a selective index of higher than 6.79, respectively.
Open AccessTwo New Bioactive α-Pyrones from Hypericum japonicum
Hypericum japonicum (Guttiferae), a type of annual or perennial herb, has been historically applied to cure infectious hepatitis, acute and chronic hepatitis, gastrointestinal disorder, and internal hemorrhage. In our successive studies on the genus Hypericum, two new α-pyrones termed japopyrones A and B (1 and 2) were isolated from H. japonicum. Their structures and absolute configurations were established by the comprehensive analyses of spectroscopic data, the application of the Single-crystal X-ray diffraction structural analysis, and the experimental electronic circular dichroism (ECD) spectra. Bioactivity screenings suggested that compound 2 possessed the potential inhibition efficacy on lytic replication of Kaposi’s sarcoma associated herpesvirus (KSHV) with an IC50 29.46 μM and a selective index of higher than 6.79, respectively.
- Open Access
A New Megastigmane Sesquiterpenoid from Zanthoxylum Schinifolium Sieb. et Zucc
Zanthoxylum schinifolium Sieb. et Zucc. (Rutaceae), a dioecious shrub with hooked prickly branches, has been used as folk medicine for the treatment of the common cold, stomach ache, diarrhea, and jaundice in China, Korea, and Japan. In our phytochemical investigations on this genus, a new megastigmane sesquiterpenoid, which is referred to as schinifolenol A (1), was isolated from Z. schinifolium. The stereochemistry was characterized via the analyses of extensive spectra. The absolute configuration was established by the application of a modified Mosher’s experiment and assisted by a time-dependent density functional theory (TD-DFT) on calculated electronic circular dichroism (ECD). Bioactivity screenings showed that compound 1 exhibited a safe hypotoxicity and a better selectivity on anti-Kaposi’s sarcoma associated herpes virus (KSHV).
Open AccessA New Megastigmane Sesquiterpenoid from Zanthoxylum Schinifolium Sieb. et Zucc
Zanthoxylum schinifolium Sieb. et Zucc. (Rutaceae), a dioecious shrub with hooked prickly branches, has been used as folk medicine for the treatment of the common cold, stomach ache, diarrhea, and jaundice in China, Korea, and Japan. In our phytochemical investigations on this genus, a new megastigmane sesquiterpenoid, which is referred to as schinifolenol A (1), was isolated from Z. schinifolium. The stereochemistry was characterized via the analyses of extensive spectra. The absolute configuration was established by the application of a modified Mosher’s experiment and assisted by a time-dependent density functional theory (TD-DFT) on calculated electronic circular dichroism (ECD). Bioactivity screenings showed that compound 1 exhibited a safe hypotoxicity and a better selectivity on anti-Kaposi’s sarcoma associated herpes virus (KSHV).
- Open Access
- 19 March 2015
- Published by Springer Nature in Scientific Reports
- Vol. 5 (1) , srep09294-9294
Indole diketopiperazines from endophytic Chaetomium sp 88194 induce breast cancer cell apoptotic death
Diketopiperazines are important secondary metabolites of the fungi with variety bioactivities. Several species belonging to genus Chaetomium produce compounds of this class, such as chetomin. To identify new antitumor agents, secondary metabolites of fungus Chaetomium sp 88194 were investigated and three new indole diketopiperazines, Chaetocochins G (1), Oidioperazines E (2) and Chetoseminudin E (3), along with two known compounds Chetoseminudins C (4) and N-acetyl-β-oxotryptamine (5), were obtained. Chaetocochins G and Chetoseminudin E were recrystallized in CHCl3 containing a small amount of MeOH and their structures with absolute configuration were established by spectroscopic data interpretation and single-crystal X-ray diffraction analysis. The absolute configuration of Oidioperazines E was defined by comparing of experimental and calculated electronic circular dichroism spectra. These isolates were also evaluated the anticancer activity and Chaetocochins G displayed more potent cytotoxicity in MCF-7 cells than the common chemotherapeutic agent (5-fluorouracil) associated with G2/M cell cycle arrest. More importantly, Chaetocochins G induced cell apoptotic death via caspase-3 induction and proteolytic cleavage of poly (ADP-ribose) polymerase, concomitantly with increased Bax and decreased Bcl-2 expression. Our findings suggested that indole diketopiperazines from endophytic Chaetomium sp 88194 may be potential resource for developing anti-cancer reagents.
- 19 March 2015
- Published by Springer Nature in Scientific Reports
- Vol. 5 (1) , srep09294-9294
Open AccessIndole diketopiperazines from endophytic Chaetomium sp 88194 induce breast cancer cell apoptotic death
Diketopiperazines are important secondary metabolites of the fungi with variety bioactivities. Several species belonging to genus Chaetomium produce compounds of this class, such as chetomin. To identify new antitumor agents, secondary metabolites of fungus Chaetomium sp 88194 were investigated and three new indole diketopiperazines, Chaetocochins G (1), Oidioperazines E (2) and Chetoseminudin E (3), along with two known compounds Chetoseminudins C (4) and N-acetyl-β-oxotryptamine (5), were obtained. Chaetocochins G and Chetoseminudin E were recrystallized in CHCl3 containing a small amount of MeOH and their structures with absolute configuration were established by spectroscopic data interpretation and single-crystal X-ray diffraction analysis. The absolute configuration of Oidioperazines E was defined by comparing of experimental and calculated electronic circular dichroism spectra. These isolates were also evaluated the anticancer activity and Chaetocochins G displayed more potent cytotoxicity in MCF-7 cells than the common chemotherapeutic agent (5-fluorouracil) associated with G2/M cell cycle arrest. More importantly, Chaetocochins G induced cell apoptotic death via caspase-3 induction and proteolytic cleavage of poly (ADP-ribose) polymerase, concomitantly with increased Bax and decreased Bcl-2 expression. Our findings suggested that indole diketopiperazines from endophytic Chaetomium sp 88194 may be potential resource for developing anti-cancer reagents.
- Open Access
- 20 November 2014
- Published by MDPI AG in Marine Drugs
- Vol. 12 (11) , 5563-5575
Five New Secondary Metabolites Produced by a Marine-Associated Fungus, Daldinia eschscholzii
Five new compounds, including a benzopyran ribonic glycoside, daldiniside A (1), two isocoumarin ribonic glycosides, daldinisides B (2) and C (3), and two alkaloids, 1-(3-indolyl)-2R,3-dihydroxypropan-1-one (4) and 3-ethyl-2, 5-pyrazinedipropanoic acid (5), along with five known compounds (6–10), were isolated from the EtOAc extract of the marine-associated fungus, Daldinia eschscholzii. Their structures were elucidated by extensive physicochemical and spectroscopic properties, besides comparison with literature data. The absolute configurations of compounds 1–3 were corroborated by chemical transformation, GC analysis and X-ray crystallographic analysis. Meanwhile, the absolute configuration of compound 4 and the planar structure of compound 6 were also determined based on the X-ray diffraction analysis. The cytotoxicity of compounds 1–10, antifungal and anti-HIV activities of compounds 1–5 and the in vitro assay for glucose consumption of compounds 1–3 were done in the anti-diabetic model, whereas none showed obvious activity.
- 20 November 2014
- Published by MDPI AG in Marine Drugs
- Vol. 12 (11) , 5563-5575
Open AccessFive New Secondary Metabolites Produced by a Marine-Associated Fungus, Daldinia eschscholzii
Five new compounds, including a benzopyran ribonic glycoside, daldiniside A (1), two isocoumarin ribonic glycosides, daldinisides B (2) and C (3), and two alkaloids, 1-(3-indolyl)-2R,3-dihydroxypropan-1-one (4) and 3-ethyl-2, 5-pyrazinedipropanoic acid (5), along with five known compounds (6–10), were isolated from the EtOAc extract of the marine-associated fungus, Daldinia eschscholzii. Their structures were elucidated by extensive physicochemical and spectroscopic properties, besides comparison with literature data. The absolute configurations of compounds 1–3 were corroborated by chemical transformation, GC analysis and X-ray crystallographic analysis. Meanwhile, the absolute configuration of compound 4 and the planar structure of compound 6 were also determined based on the X-ray diffraction analysis. The cytotoxicity of compounds 1–10, antifungal and anti-HIV activities of compounds 1–5 and the in vitro assay for glucose consumption of compounds 1–3 were done in the anti-diabetic model, whereas none showed obvious activity.
- Open Access
A New Phenolic Glycoside from the Barks of Cinnamomum cassia
A new phenolic glycoside (1), named methyl 2-phenylpropanoate-2-O-β-D-apiofuranosyl-(1→6)-O-β-D–glucopyranoside, was isolated from the barks of Cinnamomum cassia, along with three known phenolic glycosides and four known lignan glycosides. The structure of 1 was elucidated by extensive interpretation of spectroscopic data and chemical method. Selected compounds were evaluated for their immunosuppressive activities against murine lymphocytes. Compounds 1, 2, 6 and 8 exhibited differential inhibition against ConA-induced T cells proliferation.
Open AccessA New Phenolic Glycoside from the Barks of Cinnamomum cassia
A new phenolic glycoside (1), named methyl 2-phenylpropanoate-2-O-β-D-apiofuranosyl-(1→6)-O-β-D–glucopyranoside, was isolated from the barks of Cinnamomum cassia, along with three known phenolic glycosides and four known lignan glycosides. The structure of 1 was elucidated by extensive interpretation of spectroscopic data and chemical method. Selected compounds were evaluated for their immunosuppressive activities against murine lymphocytes. Compounds 1, 2, 6 and 8 exhibited differential inhibition against ConA-induced T cells proliferation.